Synchronous resection of primary colorectal tumor, liver metastases safe in some patients
the ONA take:
A recent study examined and compared patient outcomes associated with synchronous and sequential colorectal and liver resections in patients with stage IV colorectal cancer.
Generally, a combination therapy involving chemotherapy and surgical resection is used to treat colorectal cancer, but debate remains as to whether metastatic tumors should be surgically removed at the same time as the primary tumors (synchronously), as opposed to a sequential approach.
Researchers from the Mayo Clinic, led by David Nagorney, M.D., used a multi-institutional database to review a pool of 43,408 patients who underwent colorectal and liver resections for stage IV colorectal cancer. Individuals in the pool were assigned risk categories based on the extent of resection, as well as colorectal resection location.
The investigators compared outcomes within each category, comparing those that underwent synchronous colorectal and liver resections vs those who had these operations performed sequentially. The study goal was to evaluate the risk of the component operations and determine which combination of colon and liver procedures was safest.
Study data indicate that poor patient outcomes are tied more closely to the risk of individual procedures as opposed to timing. major complications are linked to the extent of resection required (liver resection or colorectal surgery).
The study data also indicate that synchronous resection of primary colorectal tumors and metastatic liver tumors is safe when minor liver resections are required.
Study results were published in Journal of Gastrointestinal Surgery.
Patient outcomes associated with synchronous and sequential colorectal and liver resections in patients with stage IV colorectal cancer.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Netupitant/Palonosetron Efficacious for Prevention of N/V in Patients Receiving MEC or HEC
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|